Literature DB >> 18334604

Human adenovirus type 52: a type 41 in disguise?

J C de Jong, A D M E Osterhaus, Morris S Jones, Balázs Harrach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18334604      PMCID： PMC2268465          DOI： 10.1128/JVI.02457-07

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  5 in total

1.  Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.

Authors:  Ijad Madisch; Gabi Harste; Heidi Pommer; Albert Heim
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications.

Authors:  K Ebner; W Pinsker; T Lion
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design.

Authors:  Ijad Madisch; Soeren Hofmayer; Christian Moritz; Alexander Grintzalis; Jens Hainmueller; Patricia Pring-Akerblom; Albert Heim
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

4.  New adenovirus species found in a patient presenting with gastroenteritis.

Authors:  Morris Saffold Jones; Balázs Harrach; Robert D Ganac; Mary M A Gozum; Wilfred P Dela Cruz; Brian Riedel; Chao Pan; Eric L Delwart; David P Schnurr
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

5.  Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool.

Authors:  J C de Jong; R Wigand; A H Kidd; G Wadell; J G Kapsenberg; C J Muzerie; A G Wermenbol; R G Firtzlaff
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327
  5 in total
  8 in total

1.  Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.

Authors:  Hongling Qiu; Xiao Li; Xingui Tian; Zhichao Zhou; Ke Xing; Haitao Li; Ni Tang; Wenkuan Liu; Peisheng Bai; Rong Zhou
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 2.  Immune evasion by adenoviruses: a window into host-virus adaptation.

Authors:  Edson R A Oliveira; Marlene Bouvier
Journal:  FEBS Lett       Date:  2019-12-05       Impact factor: 4.124

Review 3.  Ocular tropism of respiratory viruses.

Authors:  Jessica A Belser; Paul A Rota; Terrence M Tumpey
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

4.  Applying genomic and bioinformatic resources to human adenovirus genomes for use in vaccine development and for applications in vector development for gene delivery.

Authors:  Jason Seto; Michael P Walsh; Padmanabhan Mahadevan; Qiwei Zhang; Donald Seto
Journal:  Viruses       Date:  2010-01-06       Impact factor: 5.818

5.  The revolution in viral genomics as exemplified by the bioinformatic analysis of human adenoviruses.

Authors:  Sarah Torres; James Chodosh; Donald Seto; Morris S Jones
Journal:  Viruses       Date:  2010-06-28       Impact factor: 5.818

Review 6.  Viruses Causing Gastroenteritis: The Known, The New and Those Beyond.

Authors:  Bas B Oude Munnink; Lia van der Hoek
Journal:  Viruses       Date:  2016-02-08       Impact factor: 5.048

7.  An Analysis of Adenovirus Genomes Using Whole Genome Software Tools.

Authors:  Padmanabhan Mahadevan
Journal:  Bioinformation       Date:  2016-08-30

8.  High prevalence and diversity of species D adenoviruses (HAdV-D) in human populations of four Sub-Saharan countries.

Authors:  Maude Pauly; Eileen Hoppe; Lawrence Mugisha; Klara Petrzelkova; Chantal Akoua-Koffi; Emmanuel Couacy-Hymann; Augustin Etile Anoh; Arsène Mossoun; Grit Schubert; Lidewij Wiersma; Sabwe Pascale; Jean-Jacques Muyembe; Stomy Karhemere; Sabrina Weiss; Siv Aina Leendertz; Sébastien Calvignac-Spencer; Fabian H Leendertz; Bernhard Ehlers
Journal:  Virol J       Date:  2014-02-11       Impact factor: 4.099
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.